Heptares co-founder Richard Henderson awarded Nobel Prize in Chemistry
05 October 2017
We are delighted to congratulate our long-term client and Heptares Therapeutics co-founder, Richard Henderson (MRC Laboratory of Molecular Biology, Cambridge, UK) on being awarded the Nobel Prize in Chemistry 2017, together with Jacques Dubochet (University of Lausanne, Switzerland) and Joachim Frank (Columbia University, New York, USA).
These 2017 Chemistry laureates have been recognised following significant work on the development of cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution. Cryo-electron microscopy is a technique for determining three-dimensional information about protein structures at a molecular level, allowing scientists to study biological molecules in unprecedented sharpness. The detailed information that this technique provides is expected to advance the design of new drugs targeting specific proteins, thanks to the improvement of understanding in the structure and function of said proteins.
Richard Henderson co-founded Heptares Therapeutics
(“Heptares”) back in 2007 alongside Malcolm Weir, Fiona Marshall and Chris Tate, and he is a named inventor on a portfolio of patents prepared and filed for Heptares by Potter Clarkson.
Phil Thomas, Patent Attorney Partner, commented: “We are delighted that Richard Henderson’s fantastic scientific achievements have been recognised with the award of the Nobel Prize in Chemistry. Having worked with Heptares since it was founded, we are thrilled to see them flourishing as a company and the StaR technology that Richard and his colleagues helped develop being applied so successfully”
Read the full press release
on the Nobel Prize website.